No time to die: Epigenetic regulation of natural killer cell survival
Immunological Reviews,
Journal Year:
2024,
Volume and Issue:
323(1), P. 61 - 79
Published: March 1, 2024
Summary
NK
cells
are
short‐lived
innate
lymphocytes
that
can
mediate
antigen‐independent
responses
to
infection
and
cancer.
However,
studies
from
the
past
two
decades
have
shown
acquire
transcriptional
epigenetic
modifications
during
inflammation
result
in
increased
survival
lifespan.
These
findings
blur
lines
between
adaptive
arms
of
immune
system,
suggest
homeostatic
mechanisms
govern
persistence
malleable.
Indeed,
recent
undergo
continuous
strictly
regulated
adaptations
controlling
their
development,
tissue
residency,
following
inflammation.
In
this
review,
we
summarize
our
current
understanding
critical
factors
regulating
cell
throughout
lifespan,
with
a
specific
emphasis
on
regulate
various
contexts.
A
precise
molecular
will
be
important
enhance
therapies
for
cancer
infectious
diseases.
Language: Английский
Therapeutic potential of natural killer cells in neuroimmunological diseases
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
173, P. 116371 - 116371
Published: March 2, 2024
Natural
killer
(NK)
cells,
a
major
component
of
the
innate
immune
system,
have
prominent
immunoregulatory,
antitumor
proliferation,
and
antiviral
activities.
NK
cells
act
as
double-edged
sword
with
therapeutic
potential
in
neurological
autoimmunity.
Emerging
evidence
has
identified
are
involved
development
progression
neuroimmunological
diseases
such
multiple
sclerosis,
neuromyelitis
optica
spectrum
disorders,
autoimmune
encephalitis,
Guillain-Barré
Syndrome,
chronic
inflammatory
demyelinating
polyneuropathy,
myasthenia
gravis,
idiopathic
myopathy.
However,
regulatory
mechanisms
functional
roles
highly
variable
different
clinical
states
need
to
be
further
determined.
In
this
review,
we
summarize
for
heterogenic
involvement
above
conditions.
Further,
describe
cutting-edge
NK-cell-based
immunotherapy
preclinical
highlight
challenges
that
must
overcome
fully
realize
cells.
Language: Английский
LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia
Haitao Xu,
No information about this author
Dangui Chen,
No information about this author
Jia Lu
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 12, 2025
Clinical
management
of
acute
myeloid
leukemia
(AML)
poses
significant
challenges
due
to
its
poor
prognosis
and
heterogeneous
nature.
Discovering
new
biomarkers
is
crucial
for
improving
risk
assessment
customizing
treatment
approaches.
While
leukocyte-specific
transcript
1
(LST1)
implicated
in
inflammation
immune
regulation,
function
AML
remains
ambiguous.
In
this
investigation,
we
conduct
a
comprehensive
investigation
into
LST1
expression
profiles,
clinical
implications,
functional
pathways,
interactions
AML,
leveraging
multi-omics
data
experimental
validations.
Our
examination
shows
increased
levels
when
compared
regular
hematopoietic
tissues,
discovery
validated
by
RT-qPCR
Western
blot
analyses
separate
group.
Elevated
correlate
with
distinct
clinicopathological
features,
including
white
blood
cell
counts,
non-M3
FAB
subtype,
intermediate/poor
cytogenetic
risk.
Importantly,
heightened
predict
unfavorable
overall
survival
outcomes
across
various
subgroups,
independently
age
We
develop
an
integrative
nomogram
incorporating
expression,
demonstrating
robust
prognostic
efficacy
patient
survival.
Transcriptomic
profiling
identifies
275
differentially
expressed
genes
between
LST1-high
-low
cases,
enriched
cytokine
signaling,
modulation,
adhesion,
oncogenic
pathways.
Furthermore,
exhibits
associations
the
infiltration
diverse
subsets
within
microenvironment,
particularly
cells
regulatory
T
(Tregs).
conclusion,
our
study
establishes
as
novel
indicator
immunological
relevance
emphasizing
potential
therapeutic
implications.
Further
mechanistic
elucidation
pathogenesis
translation.
Language: Английский
Identification of a novel cellular senescence-related lncRNA signature for prognosis and immune response in osteosarcoma
Honglin Wu,
No information about this author
Chuanbao Deng,
No information about this author
Xiaoqing Zheng
No information about this author
et al.
Translational Cancer Research,
Journal Year:
2024,
Volume and Issue:
13(7), P. 3742 - 3759
Published: July 1, 2024
Background:
Cellular
senescence,
a
novel
hallmark
of
cancer,
is
associated
with
patient
outcomes
and
tumor
immunotherapy.
However,
at
present,
there
no
systematic
study
on
the
use
cellular
senescence-related
long
non-coding
RNAs
(CSR-lncRNAs)
to
predict
survival
in
patients
osteosarcoma.
In
this
study,
we
aimed
identify
CSR-lncRNAs
signature
evaluate
its
potential
as
prognostic
marker
predictive
tool
for
immune
response
Methods:
We
downloaded
cohort
osteosarcoma
from
The
Cancer
Genome
Atlas
(TCGA)
Gene
Expression
Omnibus
(GEO)
databases.
performed
differential
expression
co-expression
analyses
CSR-lncRNAs.
univariate
multivariate
Cox
regression
along
random
forest
algorithm
lncRNAs
significantly
correlated
senescence.
Subsequently,
assessed
models
using
curves,
receiver
operating
characteristic
nomograms,
C-index,
decision
curve
analysis.
Based
model,
were
divided
into
two
groups
according
their
risk
scores.
Then,
Ontology
Kyoto
Encyclopedia
Genes
Genomes
analyses,
compared
clinical
characteristics
uncover
functional
differences.
further
conducted
infiltration
estimation
stromal
cells
malignant
tissues
data
(ESTIMATE),
cell-type
identification
by
estimating
relative
subsets
rna
transcripts
(CIBERSORT),
single-sample
gene
set
enrichment
analysis
groups.
also
evaluated
target
genes
checkpoint
inhibitors
(ICIs).
Results:
identified
six
that
senescence
accordingly
established
lncRNA
incorporating
these
lncRNAs.
nomogram
indicated
model
was
an
independent
factor
could
This
demonstrated
high
accuracy
upon
validation.
Further
revealed
low-risk
group
exhibited
better
enhanced
infiltration.
Conclusions:
six-CSR-lncRNA
effectively
predicted
might
have
improved
Language: Английский
Nature Killer Cell for Solid Tumors: Current obstacles and prospective remedies in NK cell therapy and beyond
Critical Reviews in Oncology/Hematology,
Journal Year:
2024,
Volume and Issue:
205, P. 104553 - 104553
Published: Nov. 7, 2024
Language: Английский
DNMT1 inhibition improves the activity of memory-like natural killer cells by enhancing the level of autophagy
Yixun Li,
No information about this author
Chong Guo,
No information about this author
Fujia Zhang
No information about this author
et al.
Molecular Biology Reports,
Journal Year:
2024,
Volume and Issue:
52(1)
Published: Dec. 20, 2024
Acute
myeloid
leukemia
(AML)
is
a
common
hematological
tumor,
but
it
difficult
to
treat.
DNMT1
DNA
methyltransferase
whose
main
function
maintain
stable
methylation
during
the
replication
process.
also
plays
an
important
role
in
AML,
its
cytokine-induced
memory-like
natural
killer
(CIML
NK)
cell
activity
remains
unclear.
In
this
study,
we
isolated
primary
NK
cells
from
peripheral
blood
of
healthy
volunteers
and
AML
patients
treated
them
with
10
ng/mL
IL-12,
50
IL-15
IL-18
promote
their
differentiation
into
CIML
cells.
The
was
evaluated
by
RT‒qPCR,
western
blotting,
ELISAs,
flow
cytometry.
highly
expressed
patients.
Knocking
down
significantly
increased
expression
CD25,
CD137,
CD107a,
IFN-γ,
TNF-α
Mechanistically,
knocking
promoted
autophagy
activating
AMPK/mTOR
signaling
pathway,
thereby
enhancing
alleviating
progression
AML.
Our
study
revealed
that
downregulation
DNMT
may
be
new
target
for
treatment
Language: Английский